Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Yuling Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5289-4673; OpenAlex author ID A5044254514. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer. Co-author DOI 10.1073/pnas.2504718122↗
  2. Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic … Last author DOI 10.1016/j.csbj.2022.02.031↗
  3. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. Last author DOI 10.7554/elife.80150↗
  4. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening. Last author DOI 10.1016/j.prp.2018.10.003↗
  5. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review. Last author DOI 10.1155/2017/2646148↗
  6. Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. Co-author DOI 10.1038/srep15460↗
  7. Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer. Co-author DOI 10.1111/cas.12107↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongtao Zhu · 3 shared papers, 2015–2022 · strength 0.37
  2. Libo Wang · 2 shared papers, 2022 · strength 0.30
  3. Weijie Wang · 2 shared papers, 2022 · strength 0.30
  4. Xinwei Han · 2 shared papers, 2022 · strength 0.30
  5. Jianqiong Zhang · 1 shared paper, 2025 · strength 0.21
  6. Xue Yang · 1 shared paper, 2025 · strength 0.21
  7. Xiaoyuan Shawn Chen · 1 shared paper, 2025 · strength 0.21
  8. Ben Zhao · 1 shared paper, 2025 · strength 0.21
  9. Shenghong Ju · 1 shared paper, 2025 · strength 0.21
  10. Yuyuan Zhang · 1 shared paper, 2022 · strength 0.15
  11. Zhenjun Zhang · 1 shared paper, 2018 · strength 0.14
  12. Shuai Huang · 1 shared paper, 2017 · strength 0.12
  13. Shuai Wang · 1 shared paper, 2017 · strength 0.12
  14. Yanpeng Zhang · 1 shared paper, 2015 · strength 0.06
  15. Lin Zhou · 1 shared paper, 2013 · strength 0.04
  16. Yaozong Yuan · 1 shared paper, 2013 · strength 0.04
  17. Jiansheng Li · 1 shared paper, 2013 · strength 0.04
  18. Weiyan Yao · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.